The Hematology Journal

Title Publication Date Language Citations
Long-term management of chronic DIC associated with inoperable aortic aneurysm with low molecular weight heparin2004/01/019
SDF-1 enhances the expansion and maintenance of highly purified human hematopoietic progenitors2003/01/019
High-dose therapy in multiple myeloma2003/01/019
Histiocytic disorders2003/01/019
Acquired von Willebrand syndrome: an important bleeding complication to be considered in patients with lymphoproliferative and myeloproliferative disorders2001/01/019
Thrombosis and cancer2004/01/019
FIP1L1-PDGFRα in hypereosinophilic syndrome and mastocytosis2004/01/019
Viral infections: current diagnosis and treatment2004/01/019
Bone marrow transplantation for patients with acquired severe aplastic anemia using cyclophosphamide and antithymocyte globulin: the experience from a single center2003/01/018
Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma2003/01/018
Paraneoplastic pemphigus occuring after radiotherapy for relapsed non-Hodgkin's lymphoma in a patient with common variable immunodeficiency2003/01/018
Stem cell transplantation for chronic myeloid leukaemia: the role of infused marrow cell dose2001/01/018
Antiplatelet agents2004/01/018
Heterozygous prothrombin 20210G/A mutation, associated with hyperhomocysteinemia, and homozygous methylenetetrahydrofolate reductase 677C/T mutation, in a patient with portal and mesenteric venous thrombosis2004/01/018
In vitro effects of interferon-γ and tumor necrosis factor-α on CD34+ bone marrow progenitor cells from aplastic anemia patients and normal donors2004/01/018
Efficient ex vivo expansion of NOD/SCID-repopulating cells with lympho-myeloid potential in hematopoietic grafts of children with solid tumors2001/01/018
Hypothesis for generation of the unstable Hb Bucuresti (β 42 Phe→Leu) mutation2001/01/018
High-dose idarubicin and busulphan as conditioning for autologous stem cell transplantation in acute myeloid leukemia: a feasibility study2001/01/018
Phase II study of cyclophosphamide, interferon-α and betamethasone (CIB) as induction therapy for patients 60–75 years of age with multiple myeloma stages II and III2003/01/018
Successful paternity with microassisted fertilization after total body irradiation-based conditioning for autologous bone marrow transplantation2003/01/018
Oral fludarabine therapy in chronic lymphocytic leukemia - increased convenience2004/01/018
Impaired T-cell activation and cytokine productivity after transplantation of positively selected CD34+ allogeneic hematopoietic stem cells2004/01/018
Central role of leukemia-derived factors in the development of leukemia-associated immune dysfunction2001/01/017
A case of pancreatitis associated with all-trans-retinoic acid therapy in acute promyelocytic leukemia2001/01/017
Red cell membrane and erythropoiesis genetic defects2003/01/017
Malignant diseases of hematopoietic and lymphoid tissues in Chernobyl clean-up workers2005/01/017
Chronic myelogenous leukemia with acquired c-kit activating mutation and transient bone marrow mastocytosis2004/01/017
Second autologous transplantation after failure of a first autologous transplant in 18 patients with non-Hodgkin's lymphoma2004/01/017
Erythropoietin and erythropoiesis: polycythemias due to disruption of oxygen homeostasis2004/01/017
Overview of transplant activity in Europe2004/01/017